Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders

Core Viewpoint - Avalon GloboCare Corp. has announced a wholesale distribution agreement with Saga Health Corporation for the KetoAir™ breathalyzer device, aimed at first responders as part of Saga's Holistic Health Reset Program [1][3]. Company Overview - Avalon GloboCare Corp. (NASDAQ: ALBT) specializes in precision diagnostic consumer products and cellular therapy intellectual property [5]. - The company is currently marketing the KetoAir™ breathalyzer, which is registered as a Class I medical device with the U.S. FDA [5]. - Avalon also focuses on advancing its intellectual property portfolio through existing patent applications and operates commercial real estate [5]. Product Details - The KetoAir™ breathalyzer is designed for ketogenic health management, measuring breath acetone concentration (BrAce) to indicate fat metabolism and ketosis [2]. - It is intended for users on ketogenic diets for weight loss, athletic performance, or therapeutic purposes, utilizing nano-sensor technology for real-time insights [2]. - The device is compatible with both Apple and Android devices and is available on the Apple App Store and Google Play Store [2]. Partnership Significance - The agreement with Saga Health is seen as a milestone for accelerating the commercial expansion of the KetoAir™ device [3]. - The collaboration aims to meet the growing demand for personalized, real-time monitoring of BrAce among those pursuing ketogenic lifestyles [3]. - Saga Health's Holistic Health Reset Program provides personalized nutritional guidance and tools like the KetoAir™ breathalyzer to improve participants' health [6].